Results 131 to 140 of about 6,394 (171)

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?

European Medical Journal Diabetes, 2017
Over the last decade, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been increasingly used in the management of various retinal diseases, especially diabetic macular oedema.
Kuan Hao Yee, Srinivasan Sanjay
doaj  

Visual outcome in diabetic retinopathy with macular oedema after combined therapy with intravitreal bevacizumab and retinal photocoagulation: An observational case series

Global Journal of Medicine and Public Health
Purpose To evaluate the Visual Outcome in Diabetic Retinopathy with Macular Oedema after Combined Therapy with Intravitreal Avastin (Bevacizumab) and Retinal Photocoagulation.
Arshi Nazir, Syed T Qureshi, Ejaz Akbar, Andleeb Ahangar, Syed H Kubravi, Tania Sadiq   +5 more
doaj  

Erythropoietin and diabetic macular oedema [PDF]

Eye, 2008
A Fonollosa, J Garcia-Arumi
openaire   +1 more source

Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy

Diagnostics
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus, leading to visual impairment if left untreated. This review discusses the use of optical coherence tomography angiography (OCTA) as a diagnostic tool for the ...
Naomi Wijesingha, Wei-Shan Tsai, Ayse Merve Keskin, Christopher Holmes, Dimitrios Kazantzis, Swati Chandak, Heena Kubravi, Sobha Sivaprasad   +7 more
doaj   +1 more source

A Markov model of Diabetic Retinopathy Progression for the Economic Evaluation of a novel DR prognostic device, CHERE Working Paper 2007/14 [PDF]

The initial diagnosis of Diabetic Retinopathy (DR) is often in the advance stages of the condition, as patients are only promoted for an examination when sight has been affected.
Donald Martin, Julia Ting, Marion Haas
core  

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies

Drug Design, Development and Therapy, 2023
Yusuf Mushtaq,1,* Maryam M Mushtaq,2,* Zisis Gatzioufas,3 Matteo Ripa,4 Lorenzo Motta,5 Georgios D Panos1 1Department of Ophthalmology, Queen’s Medical Centre, Nottingham University Hospitals NHS Trust & School of Medicine, University of ...
Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD   +5 more
doaj  

A Prospective Interventional Study to Find the Effectivity of Razumab by Measuring Macular Oedema before and after Intravitreal Injection

TNOA Journal of Ophthalmic Science and Research
Aim: To test effectiveness (before and after) of a single dose of intravitreal Razumab in treatment naïve patients with macular oedema due to diabetic retinopathy or retinal vein occlusion.
V.K Malathi, Radhika Dinesh, A Rajeswari
doaj   +1 more source

How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis? [PDF]

, 2008
Haritoglou, Christos, Kampik, Anselm, Kook, Daniel, Strauss, R., Wolf, Armin   +4 more
core   +1 more source

Ophtalmologie. Rétinopathie diabétique: nouvelles possibilités thérapeutiques [Diabetic retinopathy: new therapeutic possibilities]. [PDF]

, 2015
La rétinopathie diabétique touche un nombre croissant de personnes, soit quatre millions en Europe, ce chiffre va probablement doubler d'ici 2030. Si l'on considère que 25-30% de ces patients sont atteints de rétinopathie diabétique, un dépistage et un ...
Behar-Cohen, F., Guex-Crosier, Y.
core  

Argon laser photocoagulation for diabetic macular oedema [PDF]

Eye, 2006
N E, Sinclair, A, Booth, A, Clover, R, Newsom   +3 more
openaire   +2 more sources